Vascular Access Devices for Hemodialysis Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Vascular Access Devices for Hemodialysis Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “Vascular Access Devices for Hemodialysis Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Vascular Access Devices for Hemodialysis pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Vascular Access Devices for Hemodialysis includes AV Fistula Needles, Grafts, Vascular Covered Stents and Hemodialysis Catheters.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Vascular Access Devices for Hemodialysis under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vascular Access Devices for Hemodialysis and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vascular Access Devices for Hemodialysis under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • About GlobalData
  • Introduction
    • Vascular Access Devices for Hemodialysis Overview
  • Products under Development
    • Vascular Access Devices for Hemodialysis - Pipeline Products by Stage of Development
      • Table Figure 1: Vascular Access Devices for Hemodialysis - Pipeline Products by Stage of Development
      • Table Vascular Access Devices for Hemodialysis - Pipeline Products by Stage of Development
    • Vascular Access Devices for Hemodialysis - Pipeline Products by Segment
      • Table Figure 2: Vascular Access Devices for Hemodialysis - Pipeline Products by Segment
      • Table Vascular Access Devices for Hemodialysis - Pipeline Products by Segment
    • Vascular Access Devices for Hemodialysis - Pipeline Products by Territory
      • Table Figure 3: Vascular Access Devices for Hemodialysis - Pipeline Products by Territory
      • Table Vascular Access Devices for Hemodialysis - Pipeline Products by Territory
    • Vascular Access Devices for Hemodialysis - Pipeline Products by Regulatory Path
      • Table Figure 4: Vascular Access Devices for Hemodialysis - Pipeline Products by Regulatory Path
      • Table Vascular Access Devices for Hemodialysis - Pipeline Products by Regulatory Path
    • Vascular Access Devices for Hemodialysis - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Vascular Access Devices for Hemodialysis - Pipeline Products by Estimated Approval Date
      • Table Vascular Access Devices for Hemodialysis - Pipeline Products by Estimated Approval Date
    • Vascular Access Devices for Hemodialysis - Ongoing Clinical Trials
      • Table Figure 6: Vascular Access Devices for Hemodialysis - Ongoing Clinical Trials
      • Table Vascular Access Devices for Hemodialysis - Ongoing Clinical Trials
  • Vascular Access Devices for Hemodialysis - Pipeline Products under Development by Companies
    • Vascular Access Devices for Hemodialysis Companies - Pipeline Products by Stage of Development
      • Table Vascular Access Devices for Hemodialysis Companies - Pipeline Products by Stage of Development
    • Vascular Access Devices for Hemodialysis – Companies Pipeline Products by Stage of Development
      • Table Vascular Access Devices for Hemodialysis – Companies Pipeline Products by Stage of Development
  • Vascular Access Devices for Hemodialysis Companies and Product Overview
    • Access Vascular Inc Company Overview
      • Access Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Access Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dialysis Catheter - Product Status
        • Table Dialysis Catheter - Product Description
    • Advent Access Pte Ltd Company Overview
      • Advent Access Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Advent Access Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table av-Guardian - Product Status
        • Table av-Guardian - Product Description
    • AngioDynamics Inc Company Overview
      • AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Acuswift - Product Status
        • Table Acuswift - Product Description
    • Angiotech Pharmaceuticals Inc Company Overview
      • Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table 5-FU Anti-Infective HemoStream Dialysis Catheter - Product Status
        • Table 5-FU Anti-Infective HemoStream Dialysis Catheter - Product Description Technology 5-FU Anti-infective Technology
    • Ariste Medical LLC Company Overview
      • Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Eluting Tunneled Dialysis Catheter - Product Status
        • Table Drug Eluting Tunneled Dialysis Catheter - Product Description
    • Ash Access Technology Inc Company Overview
      • Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SureFlow - Product Status
        • Table SureFlow - Product Description
    • Biosurfaces Inc Company Overview
      • Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NuSpun Vascular Graft - Product Status
        • Table NuSpun Vascular Graft - Product Description
    • Bioteque Corp Company Overview
      • Bioteque Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioteque Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fold-Proof Dialysis Catheter - Product Status
        • Table Fold-Proof Dialysis Catheter - Product Description
    • Chrysalis Medical Inc Company Overview
      • Chrysalis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Chrysalis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemodialysis Catheter - Product Status
        • Table Hemodialysis Catheter - Product Description
    • Columbia University Company Overview
      • Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemodialysis Access Flow Restrictor Device - Product Status
        • Table Hemodialysis Access Flow Restrictor Device - Product Description
    • CR Bard Inc Company Overview
      • CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glidepath LE - Product Status
        • Table Glidepath LE - Product Description
    • Healionics Corporation Company Overview
      • Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table STARgraft AV+ - Product Status
        • Table STARgraft AV+ - Product Description
    • Humacyte Inc Company Overview
      • Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Humacyl Graft - End Stage Renal Disease - Product Status
        • Table Humacyl Graft - End Stage Renal Disease - Product Description
        • Table HumaGraft - Product Status
        • Table HumaGraft - Product Description
        • Table Humacyte Inc - Ongoing Clinical Trials Overview
        • Table HumaGraft - A Phase II Assessment of Humacyte's Human Acellular Vessel in Patients Needing Vascular Access for Dialysis
        • Table HumaGraft - A Pilot Study for Evaluation of the Safety and Efficacy of Humacyte's Human Acellular Vascular Graft as an Above-knee Femoro-popliteal Bypass Graft in Patients with Peripheral Arterial Disease
        • Table HumaGraft - A Pilot Study for Evaluation of the Safety and Efficacy of Humacyte's Human Acellular Vascular Graft for Use as a Vascular Prosthesis for Hemodialysis Access in Patients with End-stage Renal Disease
        • Table Humacyl Graft - End Stage Renal Disease - A Phase 3 Study to Compare the Efficacy and Safety of Humacyte's Human Acellular Vessel with that of an Autologous Arteriovenous Fistula in Subjects with End Stage Renal Disease
        • Table Humacyl Graft - End Stage Renal Disease - An Assessment of Humacyte's Human Acellular Vessel in Patients Needing Renal Replacement Therapy: A Comparison with ePTFE Grafts as Conduits for Hemodialysis: HUMANITY
        • Table Humacyl Graft - End Stage Renal Disease - Individual Patient Expanded Access for Human Acellular Vessel (HAV)
    • InnAVasc Medical Inc Company Overview
      • InnAVasc Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table InnAVasc Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table InnAVasc Arteriovenous Graft Surgical Implant - Product Status
        • Table InnAVasc Arteriovenous Graft Surgical Implant - Product Description
        • Table InnAVasc Medical Inc - Ongoing Clinical Trials Overview
        • Table InnAVasc Arteriovenous Graft Surgical Implant - A Study to Evaluate the Safety and Effectiveness of the Innavasc Arteriovenous Graft for Hemodialysis Access in Patients with End-stage Renal Disease
    • Laminate Medical Technologies Ltd Company Overview
      • Laminate Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Laminate Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table VasQ - Product Status
        • Table VasQ - Product Description
        • Table Laminate Medical Technologies Ltd - Ongoing Clinical Trials Overview
        • Table VasQ - A Multi-center Prospective Study to Evaluate the Safety and Effectiveness of the VasQ External Support for Arteriovenous Fistula
    • Marvao Medical Devices Ltd Company Overview
      • Marvao Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Marvao Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NexSite Hemodialysis Catheter - Product Status
        • Table NexSite Hemodialysis Catheter - Product Description
    • NanoVasc, Inc. Company Overview
      • NanoVasc, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table NanoVasc, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table NanoVasc Polyurethane Graft - Product Status
        • Table NanoVasc Polyurethane Graft - Product Description
    • Nicast Ltd Company Overview
      • Nicast Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nicast Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Improved Version Of The AVflo Vascular Access Graft - Product Status
        • Table Improved Version Of The AVflo Vascular Access Graft - Product Description
    • Northwestern University Company Overview
      • Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemodialysis Needle - Product Status
        • Table Hemodialysis Needle - Product Description
    • Oxford Biomaterials Ltd Company Overview
      • Oxford Biomaterials Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Oxford Biomaterials Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table SpiderGraft - Product Status
        • Table SpiderGraft - Product Description
    • Phase One Medical LLC Company Overview
      • Phase One Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Phase One Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Goldilocks Valved Hemodialysis Catheter - Product Status
        • Table Goldilocks Valved Hemodialysis Catheter - Product Description
        • Table Reversus Hemodialysis Catheter - Product Status
        • Table Reversus Hemodialysis Catheter - Product Description
    • Phraxis, Inc. Company Overview
      • Phraxis, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Phraxis, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Phraxis InterGraft - Product Status
        • Table Phraxis InterGraft - Product Description
        • Table Phraxis, Inc. - Ongoing Clinical Trials Overview
        • Table Phraxis InterGraft - Continued Access Study of the InterGraft Venous Anastomotic Connector for Minimally Invasive Connection of an Arteriovenous Graft for Hemodialysis
    • RegenMedTX LLC Company Overview
      • RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Neo-Vessel Replacement - Vascular Access Graft - Product Status
        • Table Neo-Vessel Replacement - Vascular Access Graft - Product Description
    • Silmag SA Company Overview
      • Silmag SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Silmag SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Silicone Hemodialysis Catheter Kit - Product Status
        • Table Silicone Hemodialysis Catheter Kit - Product Description
    • TEI Biosciences Inc Company Overview
      • TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biologic Vascular Graft - Product Status
        • Table Biologic Vascular Graft - Product Description
    • University of Arizona Company Overview
      • University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
        • Table Percutaneous Vascular Anastomosis Device - Dialysis - Product Status
        • Table Percutaneous Vascular Anastomosis Device - Dialysis - Product Description
    • University of California Company Overview
      • University of California Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California Pipeline Products & Ongoing Clinical Trials Overview
        • Table Smart Dialysis Catheter - Product Status
        • Table Smart Dialysis Catheter - Product Description
    • University of Colorado Company Overview
      • University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanocomposite Material Vascular Graft - Product Status
        • Table Nanocomposite Material Vascular Graft - Product Description
    • University of Limerick Company Overview
      • University of Limerick Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Limerick Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prolong AV Graft - Product Status
        • Table Prolong AV Graft - Product Description
    • Vascoscope BV Company Overview
      • Vascoscope BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vascoscope BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vascoscope - Hemodialysis - Product Status
        • Table Vascoscope - Hemodialysis - Product Description
    • Vascudyne Inc Company Overview
      • Vascudyne Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vascudyne Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TRUE Vascular Graft - Hemodialysis - Product Status
        • Table TRUE Vascular Graft - Hemodialysis - Product Description
        • Table Vascudyne Inc - Ongoing Clinical Trials Overview
        • Table TRUE Vascular Graft - Hemodialysis - Initial Safety Study of the TRUE AVC in Hemodialysis Access (TRUE AVC I Study)
    • Vascular Genesis Company Overview
      • Vascular Genesis Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vascular Genesis Pipeline Products & Ongoing Clinical Trials Overview
        • Table The Vascular Genesis AVs - Product Status
        • Table The Vascular Genesis AVs - Product Description
    • Xeltis AG Company Overview
      • Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xeltis Hemodialysis Vascular Access Graft - Product Status
        • Table Xeltis Hemodialysis Vascular Access Graft - Product Description
        • Table Xeltis AG - Ongoing Clinical Trials Overview
        • Table Xeltis Hemodialysis Vascular Access Graft - First-in-Human (FIH) Study of the Xeltis Hemodialysis Access Graft (aXess)
        • Table Xeltis Hemodialysis Vascular Access Graft - Prospective, Non-randomized Pivotal Clinical Study to Assess the Safety and Performance of the Xeltis Hemodialysis Access Graft: aXess Pivotal Study
  • Vascular Access Devices for Hemodialysis- Recent Developments
    • Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer
    • Nov 23, 2022: Medtronic Reports Quarterly Earnings
    • Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
    • Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
    • Nov 14, 2022: Rockwell Medical Provides Business Strategy Update and Announces Third Quarter 2022 Financial and Operational Results
    • Nov 04, 2022: JMS Co. Announces Consolidated Financial Highlights for the Interim Period Ended September 2022
    • Oct 27, 2022: Teleflex Reports Third Quarter Financial Results And Full Year Outlook
    • Oct 13, 2022: Teleflex Announces Third Quarter 2022 Earnings Conference Call Information
    • Oct 13, 2022: Merit Medical Systems to Announce Third Quarter Results on October 26, 2022
    • Sep 07, 2022: Baxter to Host Third-Quarter 2022 Financial Results Conference Call for Investors
    • Sep 07, 2022: Medtronic to appear at September investor conferences
    • Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
    • Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
    • Aug 11, 2022: NanoVibronix announce quarter ended June 30, 2022
    • Aug 05, 2022: JMS Co. Announces Consolidated Financial Highlights for the Interim Period Ended June 2022
    • Jul 27, 2022: Merit Medical Reports Results for Quarter Ended June 30, 2022
    • Jul 14, 2022: Merit Medical Systems to Announce Second Quarter Results on July 27, 2022
    • Jun 28, 2022: Nipro Notice of Resolutions at the 69th Annual General Meeting of Shareholders
    • Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
    • Jun 08, 2022: Baxter to Host Second-Quarter 2022 Financial Results Conference Call for Investors
    • Jun 07, 2022: Teleflex launches new arrow pressure injectable midline catheter in Europe, the Middle East and Africa region
    • May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
    • May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
    • May 25, 2022: Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference
    • May 16, 2022: Rockwell Medical Provides First Quarter 2022 Financial and Operational Update
    • May 10, 2022: Baxter to Host 2022 Investor Conference
    • May 02, 2022: Teleflex to Host Analyst & Investor Day on May 20, 2022
    • Apr 28, 2022: Teleflex Reports First Quarter Financial Results And Full Year Outlook
    • Apr 27, 2022: Merit Medical Reports Results for Quarter Ended March 31, 2022
    • Apr 21, 2022: Merit Medical Announces Chief Operating Officer Transition
    • Apr 20, 2022: Rockwell Medical to Present at Noblecon18 Investor Conference
    • Feb 24, 2022: Teleflex Announces Fourth Quarter and Full-Year 2021 Financial Results
    • Feb 10, 2022: Baxter to Present at Citi's 2022 Virtual Healthcare Conference
    • Feb 08, 2022: JMS Announces Financial Results for the 3rd Quarter of FYE March 2022
    • Feb 03, 2022: 3M India Financial Results For The Quarter Ended December 31, 2021
    • Feb 03, 2022: 3M India Announces Appointment of Managing Director
    • Jan 31, 2022: Poly Medicure Announces Unaudited Financial Results for the Quarter and Nine Month Ended December 31 2021
    • Jan 31, 2022: Poly Medicure Announces Statement of Unaudited Standalone Financial Results for the Quarter and Nine Months Ended December 31 2021
    • Jan 13, 2022: NanoVibronix Expands Board of Directors with Appointment of Two New Independent Directors
    • Jan 06, 2022: Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors
    • Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings